Overview of Dr. Henick
Dr. Brian Henick is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Rutgers New Jersey Medical School and has been in practice 5 years. He is one of 378 doctors at New York-Presbyterian Hospital and one of 117 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. He has more than 30 publications and over 500 citings.
Office
161 Fort Washington Avenue
New York, NY 10032
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2012 - 2015
- Rutgers New Jersey Medical SchoolClass of 2012
Certifications & Licensure
- NY State Medical License 2020 - 2025
- CT State Medical License 2015 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 41 citationsGenomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.Arvind Ravi, Matthew D Hellmann, Monica B Arniella, Mark Holton, Samuel S Freeman
Nature Genetics. 2023-05-01 - 147 citationsAssociation of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-...Biagio Ricciuti, Xinan Wang, Joao V Alessi, Hira Rizvi, Navin R Mahadevan
JAMA Oncology. 2022-08-01 - 199 citationsImmune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy.Yuting Liu, Jon Zugazagoitia, Fahad Shabbir Ahmed, Brian S. Henick, Scott N. Gettinger
Clinical Cancer Research. 2020-02-15
Press Mentions
- Four New York City Cancer Centers Receive $1 Million SU2C Grant to Improve Lung Cancer Care in Underserved Minority PatientsJune 27th, 2022
- NexImmune Announces Preclinical Research Collaboration with Columbia University Irving Medical Center’s Herbert Irving Comprehensive Cancer CenterApril 26th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: